Anzeige
Mehr »
Login
Sonntag, 03.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EV4L | ISIN: US23290B1061 | Ticker-Symbol:
NASDAQ
01.11.24
17:42 Uhr
1,320 US-Dollar
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
DIH HOLDING US INC Chart 1 Jahr
5-Tage-Chart
DIH HOLDING US INC 5-Tage-Chart
GlobeNewswire (Europe)
112 Leser
Artikel bewerten:
(0)

DIH Holding US, Inc.: DIH Announces Fiscal 2025 First Quarter Financial Results

NORWELL, Mass., Aug. 19, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the quarter ended June 30, 2024, which is the first quarter of fiscal 2025.

Recent Highlights

  • Revenue of $16.2 million for the quarter ended June 30, 2024, representing growth of 24% over the prior year period
  • Device revenue of $12.3 million and service revenue of $3.5 million for the quarter ended June 30, 2024, representing growth of 18% and 49%, respectively over the prior year period
  • Revenue growth in both Europe, Middle East and Africa (EMEA) and the Americas of 54% over the prior year period
  • Gross Margin of 53.5%, representing a 12 percentage point improvement over the prior year period
  • Net loss of $0.6 million, representing improvement of $2.3 million over the prior year period
  • DIH reiterates its expected full year 2025 revenue range of $74 million to $77 million, representing growth of approximately 15% to 20% over the full year 2024

"We are very pleased with the Company's performance in the first quarter of Fiscal Year 2025, showing significant progress over the same quarter last year," said Jason Chen, Chairman and CEO of DIH. "I am excited that two of our major strategic markets, EMEA and the Americas, each achieved growth of 54% and that recurring service revenue grew by 49%. Our team has increased account penetration and enhanced productivity through workflow efficiencies, as reflected in the significant improvements in both gross margin and net income. We will continue to enrich our product solution offerings throughout the year and I remain excited about the significant growth opportunities ahead of us."

Financial Results for the First Fiscal Quarter Ended June 30, 2024

Revenue for the three months ended June 30, 2024 increased by $3.1 million, or 24.1%, to $16.2 million from $13.0 million for the three months ended June 30, 2023. The overall increase was primarily due to an increase in devices sold of $1.8 million, or 17.6% year over year. The increase in devices revenue was primarily driven by higher sales volume in EMEA. Services revenue represented an increase of $1.2 million, up 49.1% compared to the prior period. Other revenues were consistent compared to the prior period. Total revenue in EMEA and the Americas increased by $3.6 million and $1.6 million, respectively, to $10.2 million and $4.6 million for the three months ended June 30, 2024 compared to $6.6 million and $3.0 million for the three months ended June 30, 2023. The increase was partially offset by a decrease in sales in Asia.

The impact due to foreign currency translation resulted in a decrease of approximately $0.1 million in revenue for the three months ended June 30, 2024.

Gross profit for the first fiscal quarter ended June 30, 2024, was $8.7 million, an increase of 60.6% compared to the prior year period. The increase was driven by an increase of $3.1 million in sales primarily in the EMEA region. Cost of sales was improved as compared to June 30, 2023, and was driven in part by a provision adjustment in the prior year that was not recurring in the current period.

Selling, general and administrative expense for the three months ended June 30, 2024 increased by $2.8 million, or 48.2%, to $8.7 million from $5.8 million for the three months ended June 30, 2023. The increase was driven by a $0.7 million increase in professional service costs related to audit, legal and other professional services along with an investment in finance capacity to support public company reporting obligations. Additionally, the increase included a $0.7 million increase in performance-based compensation and a $0.9 million increase in overhead expenses supporting the current growth. In addition, the Company implemented new guidance for the provision of credit losses during the three months ended June 30, 2023 The adjustment during the prior period reduced reserves on receivables in the prior year and, generated a benefit to the Company in the prior year that is not recurring as of the three months ended June 30, 2024.

Research and development costs for the three months ended June 30, 2024 increased by $0.2 million, or 14.3%, to $1.6 million from $1.4 million for the three months ended June 30, 2023. The increase was primarily attributable to a $0.2 million increase in personnel expenses related to increased employee compensation.

Cash and cash equivalents on June 30, 2024 totaled $2.7 million.

Fiscal Year 2025 Outlook

The Company continues to expect gross revenue for fiscal year 2025 to range between $74 million and $77 million, representing approximately 15%-20% growth over fiscal year 2024.

About DIH Holding US, Inc.

DIH stands for the vision to "Deliver Inspiration & Health" to improve the daily lives of millions of people with disabilities and functional impairments through providing devices and solutions enabling intensive rehabilitation. DIH is a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Built through the mergers of global-leading niche technology providers, DIH is a transformative rehabilitation solutions provider and consolidator of a largely fragmented and manual-labor-driven industry.

Caution Regarding Forward-Looking Statements

This press release contains certain statements which are not historical facts, which are forward-looking statements within the meaning of the federal securities laws, for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These forward-looking statements include certain statements made with respect to the business combination, the services offered by DIH and the markets in which it operates, and DIH's projected future results. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions provided for illustrative purposes only, and projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties that could cause the actual results to differ materially from the expected results. These risks and uncertainties include, but are not limited to: general economic, political and business conditions; the ability of DIH to achieve its projected revenue, the failure of DIH realize the anticipated benefits of the recently-completed business combination and access to sources of additional debt or equity capital if needed. While DIH may elect to update these forward-looking statements at some point in the future, DIH specifically disclaims any obligation to do so.

Investor Contact
Greg Chodaczek
332-895-3230
Investor.relations@dih.com

DIH HOLDING US, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share data, unaudited)
As of June 30, 2024 As of March 31, 2024
Assets
Current assets:
Cash and cash equivalents$2,749 $3,225
Accounts receivable, net of allowances of $631 and $667, respectively 5,690 5,197
Inventories, net 9,014 7,830
Due from related party 5,728 5,688
Other current assets 6,194 5,116
Total current assets 29,375 27,056
Property, and equipment, net 664 530
Capitalized software, net 2,052 2,131
Other intangible assets, net 380 380
Operating lease, right-of-use assets, net 4,388 4,466
Other tax assets 417 267
Other assets 933 905
Total assets$38,209 $35,735
Liabilities and Deficit
Current liabilities:
Accounts payable$5,368 $4,305
Employee compensation 3,991 2,664
Due to related party 9,790 10,192
Current portion of deferred revenue 6,350 5,211
Manufacturing warranty obligation 549 513
Current portion of long-term operating lease 1,509 1,572
Current maturities of convertible debt 1,461 -
Advance payments from customers 9,272 10,562
Accrued expenses and other current liabilities 9,950 9,935
Total current liabilities 48,240 44,954
Convertible debt, net of current maturities 1,177 -
Notes payable - related party 10,722 11,457
Non-current deferred revenues 4,747 4,670
Long-term operating lease 2,925 2,917
Deferred tax liabilities 89 112
Other non-current liabilities 4,304 4,171
Total liabilities$72,204 $68,281
Commitments and contingencies
Deficit:
Preferred stock, $0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at June 30, 2024 and March 31, 2024 - -
Common stock, $0.0001 par value; 100,000,000 shares authorized; 34,544,935 shares issued and outstanding at June 30, 2024 and March 31, 2024 3 3
Additional paid-in-capital 3,685 2,613
Accumulated deficit (35,826) (35,212)
Accumulated other comprehensive income (loss) (1,857) 50
Total deficit$(33,995) $(32,546)
Total liabilities and deficit$38,209 $35,735
DIH HOLDING US, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data, unaudited)
For the Three Months Ended June 30,
2024 2023
Revenue$16,187 $13,045
Cost of sales 7,521 7,648
Gross profit 8,666 5,397
Operating expenses:
Selling, general, and administrative expense 8,676 5,837
Research and development 1,644 1,438
Total operating expenses 10,320 7,275
Operating loss (1,654) (1,878)
Other income (expense):
Interest income (expense) (135) (120)
Other income (expense), net 1,898 (689)
Total other income (expense) 1,763 (809)
Income (loss) before income taxes 109 (2,687)
Income tax expense 723 226
Net loss$(614) $(2,913)
Net loss per share, basic and diluted$(0.02) $(0.12)
Weighted average common shares outstanding, basic and diluted 34,545 25,000
DIH HOLDING US, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(in thousands, unaudited)
For the Three Months Ended June 30,
2024 2023
Net loss$(614) $(2,913)
Other comprehensive (loss) income, net of tax
Foreign currency translation adjustments, net of tax of $0 and $0 (1,388) 841
Pension liability adjustments, net of tax of $0 and $0 (291) (420)
Other comprehensive (loss) income (1,679) 421
Comprehensive loss$(2,293) $(2,492)
DIH HOLDING US, INC. AND SUBSIDIARIES
INTERIM CONDENSED COMBINED STATEMENTS OF CHANGES IN EQUITY (DEFICIT)
(in thousands, unaudited)
Common Stock
Shares(1) Amount Additional Paid-In Capital Accumulated Deficit Accumulated Other Comprehensive Income (Loss) Total Equity (Deficit)
Balance, March 31, 2023 25,000,000 $2 $(1,898)$(26,769)$(289)$(28,954)
Net loss - - - (2,913) - (2,913)
Other comprehensive loss, net of tax - - - - 421 421
Balance, June 30, 2023 25,000,000 $2 $(1,898)$(29,682)$132 $(31,446)
Shares Amount Additional Paid-In Capital Accumulated Deficit Accumulated Other Comprehensive Income (Loss) Total Equity (Deficit)
Balance, March 31, 2024 34,544,935 $3 $2,613 $(35,212)$50 $(32,546)
Net loss - - - (614) - (614)
Transaction relates to reverse recapitalization - - 710 - - 710
Issuance of warrants - - 362 - - 362
Other comprehensive income, net of tax - - - - (1,907) (1,907)
Balance, June 30, 2024 34,544,935 $3 $3,685 $(35,826)$(1,857)$(33,995)
DIH HOLDING US, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)
For the Three Months Ended June 30,
2024 2023
Cash flows from operating activities:
Net loss$(614) $(2,913)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization 91 79
Provision for credit losses (36) (432)
Allowance for inventory obsolescence (13) 693
Pension contributions (150) (150)
Pension expense 77 66
Foreign exchange (gain) loss (1,899) 689
Noncash lease expense 422 375
Noncash interest expense - 7
Deferred and other noncash income tax (income) expense (166) 4
Changes in operating assets and liabilities:
Accounts receivable (489) 705
Inventories (1,468) (1,332)
Due from related parties (108) 1,522
Due to related parties (584) (649)
Other assets (872) (398)
Operating lease liabilities (425) (518)
Accounts payable 1,508 36
Employee compensation 1,388 (160)
Other liabilities - 189
Deferred revenue 1,411 209
Manufacturing warranty obligation 50 71
Advance payments from customers (1,136) 2,229
Accrued expense and other current liabilities 1,003 (797)
Net cash used in operating activities (2,010) (475)
Cash flows from investing activities:
Purchases of property and equipment (235) (15)
Net cash used in investing activities (235) (15)
Cash flows from financing activities:
Proceeds from issuance of convertible debt, net of issuance costs 2,509 -
Payments on related party notes payable (735) (1,936)
Net cash provided by (used in) financing activities 1,774 (1,936)
Effect of currency translation on cash and cash equivalents (5) 13
Net increase in cash, and cash equivalents, and restricted cash (476) (2,413)
Cash, and cash equivalents - beginning of period 3,225 3,175
Cash, and cash equivalents - end of period$2,749 $762
Supplemental disclosure of cash flow information:
Interest paid$135 $113
Income tax paid$- $-
Supplemental disclosure of non-cash investing and financing activity:
Accounts payable settled upon reverse recapitalization$710 $-

© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.